Sugi Predict

Sugi Predict / Compounds / SCHEMBL14645928

SCHEMBL14645928

SCHEMBL14645928

O=C(O)Cc1cc(Cl)sc1-c1ccc(-c2sc(-c3ccc(-c4cc(CC(=O)O)c(-c5ccc(-c6sc(Cl)cc6CC(=O)O)s5)s4)s3)cc2CC(=O)O)s1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.36
▸ NFE2L2 Q16236 1/20 0.36
▸ DAO P14920 1/20 0.35
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ AKR1B1 P15121 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ CXCL8 P10145 3/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CAMK2A Q9UQM7 4/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CHRM1 P11229 1/20 0.31
▸ RPS6KB2 Q9UBS0 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15695273 0.91 ESR1 (0.32) KEAP1NFE2L2MEN1KMT2ARXFP1
SCHEMBL14646247 0.85 PTGER1 (0.39) DAORPS6KB2
SCHEMBL17803947 0.85 RXRA (0.30) MEN1KMT2ARXFP1
SCHEMBL14773880 0.82 SRC (0.36) KEAP1NFE2L2MEN1KMT2ARXFP1
SCHEMBL9976569 0.82 DAO (0.36) KEAP1NFE2L2DAOMEN1KMT2A
SCHEMBL14646131 0.82 POLB (0.41) MEN1KMT2AALDH1A1RPS6KB2
SCHEMBL14773967 0.82 GABRP (0.35) KEAP1NFE2L2MEN1KMT2ARXFP1
SCHEMBL14773916 0.82 TSHR (0.33) KEAP1NFE2L2MEN1KMT2ARXFP1
SCHEMBL14645296 0.82 POLB (0.41) MEN1KMT2AALDH1A1RPS6KB2
SCHEMBL14645594 0.82 MEN1 (0.37) KEAP1NFE2L2DAOMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359311-B2 Substituted aromatic oligomers NEUROSCIOS GMBH (AT) 2016-06-07 — — US disclosed
US-9359311-B2 Substituted aromatic oligomers NEUROSCIOS GMBH (AT) 2016-06-07 — — US disclosed
EP-2817304-A1 NOVEL COMPOUNDS AND THEIR USE IN THERAPY BioChromix NewCo AB (SE) 2014-12-31 — — EP disclosed
US-20140135322-A1 NOVEL COMPOUNDS AND THEIR USE IN THERAPY BIOCHROMIX PHARMA AB 2014-05-15 — — US disclosed
US-20140135322-A1 NOVEL COMPOUNDS AND THEIR USE IN THERAPY BIOCHROMIX PHARMA AB 2014-05-15 — — US disclosed
WO-2013036196-A1 NOVEL THIOPHENE COMPOUNDS AND METHOD FOR IN VIVO IMAGING BIOCHROMIX AB (SE) 2013-03-14 — — WO disclosed
WO-2013009259-A1 NOVEL COMPOUNDS AND THEIR USE IN THERAPY BIOCHROMIX PHARMA AB (SE) 2013-01-17 — — WO disclosed
WO-2013009259-A1 NOVEL COMPOUNDS AND THEIR USE IN THERAPY BIOCHROMIX PHARMA AB (SE) 2013-01-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140135322-A1 NOVEL COMPOUNDS AND THEIR USE IN THERAPY PRNP, TBCA, HSPA5 KEAP1 49/4885NFE2L2 400/4885DAO 1592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.